By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



9987 Carver Road, Suite 420

Cincinnati  Ohio  45242 
Phone: 513-985-1920 Fax: 513-985-0999



Company News
Aerpio Announces Publication Of Preclinical Data On AKB-9778 For Common Eye Diseases 9/3/2014 12:48:40 PM
Aerpio Presents Full Results From Phase 1b/2a Study Of AKB-9778 For The Treatment Of Diabetic Macular Edema At Association for Research in Vision & Ophthalmology Annual Meeting 5/5/2014 9:54:32 AM
Aerpio Closes $22 Million Financing 4/23/2014 8:31:02 AM
Aerpio Initiates Phase 2 Study Of Tie2 Activator AKB-9778 For The Treatment Of Diabetic Macular Edema 2/13/2014 9:12:37 AM
Aerpio Announces Successful Completion of Phase 1b/2a Trial in Diabetic Macular Edema and $9 Million Series A Extension 11/6/2013 10:13:55 AM
Aerpio Announces Publication of Data on Tie2 Activator, AKB-9778, Supporting Future Clinical Development in Cancer 8/5/2013 9:39:45 AM
Aerpio Initiates Phase 1b/2a Trial of AKB-9778 in Diabetic Macular Edema 9/19/2012 10:06:25 AM
Aerpio Raises $27 Million 8/31/2012 7:49:03 AM
Aerpio Completes $27 Million Series A Financing 8/30/2012 7:51:35 AM
Aerpio Appoints Dr. Adrienne Graves to Board of Directors 5/10/2012 10:35:23 AM